Papers
9
Total Citations
907
H-Index
5
About
Alex Gorbonos is a leading urologic oncologist whose research has fundamentally shaped the surgical management of bladder and prostate cancer. His most impactful work centers on the landmark RAZOR trial, a phase 3, non-inferiority study that compared robot-assisted radical cystectomy (RARC) to open radical cystectomy (ORC). With over 760 citations, this trial demonstrated that RARC is non-inferior to ORC in 2-year progression-free survival, providing high-level evidence for the robotic approach. Gorbonos has continued to mine this rich dataset, publishing influential follow-up analyses on 3-year survival outcomes (115 citations), complication and readmission rates, and opioid prescribing patterns, all of which have helped refine perioperative care. Beyond cystectomy, his work explores the feasibility of Retzius-sparing prostatectomy and the comparative outcomes of robotic versus open surgery for large renal masses and ureteral reimplantation. His research consistently addresses practical clinical questions—such as extraction site hernia prevention—demonstrating a commitment to improving patient recovery and long-term outcomes. Through rigorous randomized trial methodology and sustained follow-up, Gorbonos has provided the urologic community with essential data to guide surgical decision-making and advance the evidence base for robotic surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4Ureteral Reimplantation in Adults: Open Versus Robotic7 citations · 2014
- 5
- 6
- 7
- 8A Case of Renal Metastasis of Uterine Leiomyosarcoma3 citations · 2017
- 9